In this special episode filmed in Hong Kong at the 2026 Joint Vision Academy Steering Committee and Barometer Leadership Coalition meeting, I am joined by Professor Tien Yin Wong, Vice Provost and Chair Professor at the University of Tsinghua, Beijing, China, and previous Chairman of the Singapore Eye Research Institute, Singapore. Join us as we explore the concept of oculomics, including history of the field and its clinical implications. We dive into the recent interest in oculomics, its potential in enabling early detection of various systemic diseases, and how it may be employed by healthcare professionals to provide more personalized and accessible patient care. Finally, we discuss what challenges remain in integrating oculomics into clinical practice. To learn more about oculomics, read the paper on current concept and evidence of oculomics, co-authored by Tien. To find out more about the impact of AI on screening, diagnosis, and management of retinal disease, read the Vision Academy Consensus and publication. For more information about patient-focused care, visit the nAMD Barometer and DR Barometer websites. If you enjoyed this episode, SUBSCRIBE to “A Chat with Anat” to make sure you never miss an episode! Speaker disclosures: Professor Anat Loewenstein Consultant: 4DMT, AbbVie, Astellas, Bayer, Beyeonics, Eyepoint, Notal Vision, Ocular Therapeutix, Ocuphire, Oculis, Opthea, Roche, Boehringer-Ingelheim, Aviceda, Voiant Professor Tien Yin Wong Consultant: Aldropika Therapeutics, Bayer, Boehringer-Ingelheim, Eden Ophthalmic, Genentech, Iveric Bio/Astellas Pharma, Novartis, Oxurion, Plano, Roche, Sanofi, Shanghai Henlius, and Zhaoke Pharmaceutical; and holds patents for and is the co-founder: EyRiS and Visre. June 2026 | PP-PF-OPHT-ALL-0303-1 This podcast series is intended for HCPs, and is not intended for UK audiences. Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing. This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise. The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program. The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.
